JP2007506726A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007506726A5 JP2007506726A5 JP2006527499A JP2006527499A JP2007506726A5 JP 2007506726 A5 JP2007506726 A5 JP 2007506726A5 JP 2006527499 A JP2006527499 A JP 2006527499A JP 2006527499 A JP2006527499 A JP 2006527499A JP 2007506726 A5 JP2007506726 A5 JP 2007506726A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- pyridyl
- fluorine atoms
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000001153 fluoro group Chemical group F* 0.000 claims 41
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 28
- 125000004076 pyridyl group Chemical group 0.000 claims 28
- 125000000217 alkyl group Chemical group 0.000 claims 23
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 19
- 229910052739 hydrogen Inorganic materials 0.000 claims 18
- 239000001257 hydrogen Substances 0.000 claims 18
- 239000008194 pharmaceutical composition Substances 0.000 claims 17
- 125000001424 substituent group Chemical group 0.000 claims 16
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 15
- -1 respectively Chemical group 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 12
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 11
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 208000035475 disorder Diseases 0.000 claims 6
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 5
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 208000024891 symptom Diseases 0.000 claims 3
- 208000023105 Huntington disease Diseases 0.000 claims 2
- 208000008238 Muscle Spasticity Diseases 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 206010007710 Cartilage injury Diseases 0.000 claims 1
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 206010021118 Hypotonia Diseases 0.000 claims 1
- 208000001456 Jet Lag Syndrome Diseases 0.000 claims 1
- 208000008930 Low Back Pain Diseases 0.000 claims 1
- 208000007379 Muscle Hypotonia Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000008705 Nocturnal Myoclonus Syndrome Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 206010033799 Paralysis Diseases 0.000 claims 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 claims 1
- 206010041247 Social fear Diseases 0.000 claims 1
- 206010041250 Social phobia Diseases 0.000 claims 1
- 238000001467 acupuncture Methods 0.000 claims 1
- 230000004075 alteration Effects 0.000 claims 1
- 208000022531 anorexia Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 230000019771 cognition Effects 0.000 claims 1
- 206010061428 decreased appetite Diseases 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 208000023515 periodic limb movement disease Diseases 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 230000005586 smoking cessation Effects 0.000 claims 1
- 208000018198 spasticity Diseases 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000004584 weight gain Effects 0.000 claims 1
- 235000019786 weight gain Nutrition 0.000 claims 1
- 0 CC(C*)CC(CC(O)=O)N Chemical compound CC(C*)CC(CC(O)=O)N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50600303P | 2003-09-25 | 2003-09-25 | |
| PCT/IB2004/002978 WO2005030184A2 (en) | 2003-09-25 | 2004-09-13 | Therapeutic beta aminoacids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007506726A JP2007506726A (ja) | 2007-03-22 |
| JP2007506726A5 true JP2007506726A5 (cg-RX-API-DMAC7.html) | 2007-10-18 |
Family
ID=34393101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006527499A Withdrawn JP2007506726A (ja) | 2003-09-25 | 2004-09-13 | α２δ−タンパク質に対する親和性を有するアミノ酸の使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7112610B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1670452A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007506726A (cg-RX-API-DMAC7.html) |
| KR (1) | KR100774625B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1856301A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004275572A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0414798A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2539976A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL173862A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06003381A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20061801L (cg-RX-API-DMAC7.html) |
| RU (2) | RU2344121C2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200511989A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005030184A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200602450B (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103534258B (zh) | 2011-05-17 | 2016-09-14 | 普林斯匹亚生物制药公司 | 酪氨酸激酶抑制剂 |
| US9376438B2 (en) | 2011-05-17 | 2016-06-28 | Principia Biopharma, Inc. | Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors |
| BR112013029508B1 (pt) | 2011-05-17 | 2022-05-03 | Principia Biopharma, Inc. | Composto, composição farmacêutica, e, uso do referido composto |
| LT3181567T (lt) | 2012-09-10 | 2019-07-25 | Principia Biopharma Inc. | Pirazolpirimidino junginiai kaip kinazės slopikliai |
| US8957080B2 (en) | 2013-04-09 | 2015-02-17 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
| KR20220027271A (ko) | 2014-02-21 | 2022-03-07 | 프린시피아 바이오파마, 인코퍼레이티드 | Btk 억제제의 염 및 고체 형태 |
| ES2843323T3 (es) | 2014-12-18 | 2021-07-16 | Principia Biopharma Inc | Tratamiento de pénfigo |
| US20180305350A1 (en) | 2015-06-24 | 2018-10-25 | Principia Biopharma Inc. | Tyrosine kinase inhibitors |
| CN109600989B (zh) | 2016-06-29 | 2022-11-04 | 普林斯匹亚生物制药公司 | 2-[3-[4-氨基-3-(2-氟-4-苯氧基-苯基)吡唑并[3,4-d]嘧啶-1-基]哌啶-1-羰基]-4-甲基-4-[4-(氧杂环丁烷-3-基)哌嗪-1-基]戊-2-烯腈的改性的释放制剂 |
| KR20220080179A (ko) | 2019-10-14 | 2022-06-14 | 프린시피아 바이오파마, 인코퍼레이티드 | (R)-2-[3-[4-아미노-3-(2-플루오로-4-페녹시-페닐)피라졸로[3,4-d]피리미딘-1-일]피페리딘-1-카르보닐]-4-메틸-4-[4-(옥세탄-3-일)피페라진-1-일]펜트-2-엔니트릴을 투여하여 면역 혈소판 감소증을 치료하는 방법 |
| KR20220130184A (ko) | 2020-01-22 | 2022-09-26 | 프린시피아 바이오파마, 인코퍼레이티드 | 2-[3-[4-아미노-3-(2-플루오로-4-페녹시-페닐)-1H-피라졸로[3,4-d]피리미딘-1-일]피페리딘-1-카르보닐]-4-메틸-4-[4-(옥세탄-3-일)피페라진-1-일]펜트-2-엔니트릴의 결정질 형태 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE312347T1 (de) * | 1991-08-23 | 2005-12-15 | Nps Pharma Inc | Screening-verfahren für kalzium-rezeptor aktive verbindungen |
| US6306909B1 (en) * | 1997-03-12 | 2001-10-23 | Queen's University At Kingston | Anti-epileptogenic agents |
| FR2791982B1 (fr) * | 1999-04-06 | 2002-12-27 | Inst Nat Sante Rech Med | Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques. |
| EP1386166A2 (en) * | 2001-03-13 | 2004-02-04 | Queen's University At Kingston | Anti-epileptogenic agents |
| NI200300043A (es) * | 2002-03-28 | 2003-11-05 | Warner Lambert Co | AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA. |
| GB0219024D0 (en) * | 2002-08-15 | 2002-09-25 | Pfizer Ltd | Synergistic combinations |
| CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
| US20050043345A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of addiction in a mammal |
| US20050043407A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the prevention and treatment of addiction in a mammal |
| US20050043406A1 (en) * | 2003-08-22 | 2005-02-24 | Pfizer Inc | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
-
2004
- 2004-09-13 MX MXPA06003381A patent/MXPA06003381A/es unknown
- 2004-09-13 KR KR1020067005783A patent/KR100774625B1/ko not_active Expired - Fee Related
- 2004-09-13 CA CA002539976A patent/CA2539976A1/en not_active Abandoned
- 2004-09-13 BR BRPI0414798-7A patent/BRPI0414798A/pt not_active IP Right Cessation
- 2004-09-13 RU RU2006107650/04A patent/RU2344121C2/ru not_active IP Right Cessation
- 2004-09-13 CN CNA2004800277659A patent/CN1856301A/zh active Pending
- 2004-09-13 WO PCT/IB2004/002978 patent/WO2005030184A2/en not_active Ceased
- 2004-09-13 EP EP04769367A patent/EP1670452A2/en not_active Withdrawn
- 2004-09-13 JP JP2006527499A patent/JP2007506726A/ja not_active Withdrawn
- 2004-09-13 AU AU2004275572A patent/AU2004275572A1/en not_active Abandoned
- 2004-09-24 TW TW093129003A patent/TW200511989A/zh unknown
- 2004-09-24 US US10/950,094 patent/US7112610B2/en not_active Expired - Fee Related
-
2006
- 2006-02-21 IL IL173862A patent/IL173862A0/en unknown
- 2006-03-24 ZA ZA200602450A patent/ZA200602450B/en unknown
- 2006-04-24 NO NO20061801A patent/NO20061801L/no not_active Application Discontinuation
- 2006-06-30 US US11/480,010 patent/US20060247282A1/en not_active Abandoned
-
2008
- 2008-09-19 RU RU2008137379/04A patent/RU2008137379A/ru not_active Application Discontinuation